Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Decitabine Combined with Minimally Myelosuppressive Therapy for Induction of Remission of Pediatric High-Risk Acute Myeloid Leukemia with Chromosome 5q Deletion. a Report of Three Cases

Shengqin Cheng, Peifang Xiao, Juxiang Wang, Li Gao, Jiajia Zheng, Yixin Hu, Xin Ding, Jing Ling, Qin Lu, Jian Pan, Bohan Li, Jun Lu, Yi Wang, Raul C Ribeiro, Shaoyan Hu

Blood (2021) 138 (Supplement 1): 4427.

DOI: https://doi.org/10.1182/blood-2021-151594

Published: 2021

Journal Articles

Identification of Chemo-Resistant Residual Cell Population in Pediatric AML of Complete Remission By Single Cell RNA Sequencing

Shuting Jiang, Fuhong He, PhD, Li Gao, MD, Aili Chen, PhD, Yixin Hu, MD, Liyan Fan, MD, Lin Zhang, MS, Yongping Zhang, Haiyang Hu, Dan Liu, MS, Zihan Zhou, Yanxun Su, Lei Qin, Jun Lu, MD, Peifang Xiao, MD, Raul Ribeiro, MD, Shaoyan Hu, MD PhD, Qian-fei Wang, PhD

Blood (2020) 136 (Supplement 1): 25–26.

DOI: https://doi.org/10.1182/blood-2020-141139

Published: 2020

Journal Articles

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Bohan Li, Xinran Chu, Lijun Meng, PhD, Peifang Xiao, MD, Jie Li, MD, Jun Lu, MD, Yi Zhang, MD PhD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 3288.

DOI: https://doi.org/10.1182/blood-2019-128191

Published: 2019

Journal Articles

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

Yixin Hu, MD, Li Gao, MD, Aili Chen, MD, Jun Lu, MD, Jie Li, MD, Hailong He, MD, Yi Wang, MD PhD, Peifang Xiao, MD, Qianfei Wang, PhD, Raul Ribeiro, MD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 2613.

DOI: https://doi.org/10.1182/blood-2019-129572

Published: 2019

Journal Articles

The Related Factors and the Prognosis of Nervous System Complications on the Pediatric Patients with Hematopoietic Stem Cell Transplantation

Suxiang Liu, MD, Defei Zheng, MD, Peifang Xiao, MD, Yi Wang, MD, Zong Zhai, MD, Jun Lu, MD, Jie Li, MD, Shaoyan Hu, MD PhD

Blood (2018) 132 (Supplement 1): 5718.

DOI: https://doi.org/10.1182/blood-2018-99-117803

Published: 2018

Journal Articles

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Mitoxantrone in Pediatric Refractory and Relapse Acute Myeloid Leukemia and MDS-Raebt

Liyan Fan, MD, Aili Chen, MD, Yixin Hu, MD, Peifang Xiao, MD, Jun Lu, MD, Jie Li, MD, Hailong He, MD, Yi Wang, MD, Shaoyan Hu, MD PhD

Blood (2018) 132 (Supplement 1): 5175.

DOI: https://doi.org/10.1182/blood-2018-99-117850

Published: 2018

Journal Articles

Reduction of Graft Rejection By Fludarabine Combined Busulfan, Cyclophosphamide and Antithymocyte Globulin Conditioning in Cord Blood Transplantation for Children with Wiskott-Aldrich Syndrome

Peifang Xiao, MD, Jun Lu, MD, Jie Li, MD, Defei Zheng, MD, Li Gao, MD, Ailian Guo, MD, Hu Liu, MD, Suxiang Liu, MD, Hailong He, MD, Shaoyan Hu, MD PhD

Blood (2018) 132 (Supplement 1): 5714.

DOI: https://doi.org/10.1182/blood-2018-99-117748

Published: 2018

Journal Articles

Repeated Transfusion of Granulocytes to Control Multidrug-Resistant Pseudomonas Aeruginosa Sepsis in Haploidentical Hematopoietic Stem Cell Transplant Patients during Pre-Engraftment Stage

Yixin Hu, MD, Ruonan Sun, Jun Lu, MD, Peifang Xiao, MD, Jie Li, MD, Defei Zheng, MD, Shaoyan Hu, MD PhD

Blood (2018) 132 (Supplement 1): 4946.

DOI: https://doi.org/10.1182/blood-2018-99-117832

Published: 2018

Journal Articles

Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma

Blood (2018) 131 (23): 2552–2567.

DOI: https://doi.org/10.1182/blood-2017-07-794529

Published: 2018

Includes: Supplemental data

Journal Articles

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

Tae Kon Kim, MD PhD, Xue Han, PhD, Jun Wang, PhD, Miguel Sanmamed, MD, Tianxiang Zhang, PhD, Stephanie Halene, MD PhD, Manoj M Pillai, MD, Jun Lu, PhD, Mina Xu, MD, Amer M. Zeidan, MD, Steven D. Gore, MD, Madhav V Dhodapkar, MBBS, Lieping Chen, MD PhD

Blood (2017) 130 (Supplement 1): 2658.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2658.2658

Published: 2017

Journal Articles

Preliminary Mechanism Study of MYBL2 Gene in Acute Myeloid Leukemia Cells

Jun Lu, MD, Weiwei DU, Shaoyan Hu, MD PhD, Jian PAN, PhD

Blood (2017) 130 (Supplement 1): 5029.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5029.5029

Published: 2017

Journal Articles

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Blood (2017) 130 (Supplement 1): 1397.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1397.1397

Published: 2017

Journal Articles

Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations

Blood (2017) 129 (24): 3264–3268.

DOI: https://doi.org/10.1182/blood-2017-03-771162

Published: 2017

Includes: Supplemental data

Journal Articles

miR-125b promotes MLL-AF9 –driven murine acute myeloid leukemia involving a VEGFA -mediated non–cell-intrinsic mechanism

Jun Liu, Bo Guo, Zhuo Chen, Nayi Wang, Michelina Iacovino, Jijun Cheng, Christine Roden, Wen Pan, Sajid Khan, Suning Chen, Michael Kyba, Rong Fan, Shangqin Guo, Jun Lu

Blood (2017) 129 (11): 1491–1502.

DOI: https://doi.org/10.1182/blood-2016-06-721027

Published: 2017

Includes: Supplemental data

Journal Articles

Analysis of Prognostic Factors in Chinese Pediatric Acute Myeloid Leukemia

Shaoyan Hu, MD PhD, Li Gao, MD, Yi Wang, MD PhD, Hailong He, MD, Jun Lu, MD, Peifang Xiao, MD, Hui Lv, MD, Yina Sun, MD, Junjie Fan, MD, Ye Lu, MD, Hu Liu, MD, Zhizhuo Du, MD

Blood (2016) 128 (22): 5258.

DOI: https://doi.org/10.1182/blood.V128.22.5258.5258

Published: 2016

Journal Articles

Molecular Mechanism Analysis the Apoptosis of Leukemia Cells Induced By CRM1 Selective Inhibitor KPT-330

Jun Lu, Shaoyan Hu, MD PhD, Weiwei DU, Jian Pan, Junli Ren, Li Zhiheng

Blood (2016) 128 (22): 5901.

DOI: https://doi.org/10.1182/blood.V128.22.5901.5901

Published: 2016

Journal Articles

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

Aili Chen, PhD, Yixin Hu, MD, Xin Liu, MD PhD, Jun Lu, MD, Peifang Xiao, MD, Xinchang Zheng, Jin Yang, Ya Zhang, Jingyi Yang, MD, Fuhong He, PhD, Pinpin Sui, Hailong He, MD, Yi Wang, MD PhD, Cheng Cheng, PhD, Raul C. Ribeiro, MD, Shaoyan Hu, MD PhD, Qianfei Wang, PhD

Blood (2016) 128 (22): 2848.

DOI: https://doi.org/10.1182/blood.V128.22.2848.2848

Published: 2016

Journal Articles

Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor

Yaozu Xiang, Jijun Cheng, Dandan Wang, Xiaoyue Hu, Yi Xie, Jeremiah Stitham, Gourg Atteya, Jing Du, Wai Ho Tang, Seung Hee Lee, Kristen Leslie, Geralyn Spollett, Zejian Liu, Erica Herzog, Raimund I. Herzog, Jun Lu, Kathleen A. Martin, John Hwa

Blood (2015) 125 (22): 3377–3387.

DOI: https://doi.org/10.1182/blood-2015-01-620278

Published: 2015

Includes: Supplemental data

Journal Articles

The Outcome of Childhood Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Treated with the Protocol (CCLG-ALL2008)

Yina SUN, Yi-huan Chai, MD, Hai-long He, MD, Jun LU, Yi WANG, Wen-li Zhao, Pei-fang Xiao, Jun-jie Fan, Shaoyan Hu, MD PhD

Blood (2014) 124 (21): 5243.

DOI: https://doi.org/10.1182/blood.V124.21.5243.5243

Published: 2014

Journal Articles

WBC More Than 300 *10 9 /L Confers an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia Patients Treated By Protocol(CCLG-2008 )

Shaoyan Hu, MD PhD, Xiao-yan Yang, Hai-long He, MD, Jun LU, Yi WANG, Wenli Zhao, Peifang Xiao, Yi-huan Chai

Blood (2014) 124 (21): 5244.

DOI: https://doi.org/10.1182/blood.V124.21.5244.5244

Published: 2014

NARROW

Decitabine Combined with Minimally Myelosuppressive Therapy for Induction of Remission of Pediatric High-Risk Acute Myeloid Leukemia with Chromosome 5q Deletion. a Report of Three Cases

Identification of Chemo-Resistant Residual Cell Population in Pediatric AML of Complete Remission By Single Cell RNA Sequencing

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

The Related Factors and the Prognosis of Nervous System Complications on the Pediatric Patients with Hematopoietic Stem Cell Transplantation

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Mitoxantrone in Pediatric Refractory and Relapse Acute Myeloid Leukemia and MDS-Raebt

Reduction of Graft Rejection By Fludarabine Combined Busulfan, Cyclophosphamide and Antithymocyte Globulin Conditioning in Cord Blood Transplantation for Children with Wiskott-Aldrich Syndrome

Repeated Transfusion of Granulocytes to Control Multidrug-Resistant Pseudomonas Aeruginosa Sepsis in Haploidentical Hematopoietic Stem Cell Transplant Patients during Pre-Engraftment Stage

Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

Preliminary Mechanism Study of MYBL2 Gene in Acute Myeloid Leukemia Cells

Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction

Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations

miR-125b promotes MLL-AF9 –driven murine acute myeloid leukemia involving a VEGFA -mediated non–cell-intrinsic mechanism

Analysis of Prognostic Factors in Chinese Pediatric Acute Myeloid Leukemia

Molecular Mechanism Analysis the Apoptosis of Leukemia Cells Induced By CRM1 Selective Inhibitor KPT-330

Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen

Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor

The Outcome of Childhood Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Treated with the Protocol (CCLG-ALL2008)

WBC More Than 300 *10 9 /L Confers an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia Patients Treated By Protocol(CCLG-2008 )

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only